Hiep Ngo, MD
Neurology · Morgan Hill
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 32
- 8 carriers
- Offices
- 3
Offices
3 locations · Bass Medical Group · 292 clinicians in this group
Looking this up.
Hospitals listed: Hazel Hawkins Memorial Hospital · Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
32 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ngo’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
32 of 32 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A79159 · Current
Licensed to practise in California · since 2002 · expires 2027-12-31 · Virginia Commonwealth University, Medical College of Virginia.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Hazel Hawkins Memorial HospitalHollister, CACritical Access Hospital · Government - Hospital District or Authority · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Hazel Hawkins Memorial Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.1) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 43 cases | No different | Jan 2024 – Dec 2024 |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$145,197
Medicare paid this office $145,197 for 538 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| New patient visit (45+ min) | 277 | $42,073 | $152 |
| Return visit (30+ min) | 196 | $27,234 | $118 |
| Short return visit (20+ min) | 194 | $17,393 | $77 |
| Muscle electrical test | 74 | $15,675 | $102 |
| Nerve test | 34 | $9,697 | $285 |
See all 12 services
| New patient visit (45+ min) | 277 | $42,073 | $152 |
| Return visit (30+ min) | 196 | $27,234 | $118 |
| Short return visit (20+ min) | 194 | $17,393 | $77 |
| Muscle electrical test | 74 | $15,675 | $102 |
| Nerve test | 34 | $9,697 | $285 |
| Nerve test | 44 | $9,551 | $217 |
| Testing of autonomic (sympathetic) nervous system function | 51 | $6,470 | $127 |
| Exam of neurobehavioral status, first hour | 68 | $5,842 | $86 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 173 | $3,039 | $15 |
| Long return visit (40+ min) | 11 | $1,831 | $166 |
| Muscle electrical test | 15 | $871 | $51 |
| Test or measurement for functional capacity, each 15 minutes | 12 | $417 | $35 |
Who their Medicare patients are
538 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 18% · Women 55% · Also on Medicaid 8% · Health risk score 1.22. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Diabetes 30% · Coronary heart disease 29% · Chronic kidney disease 23% · Dementia 22% · Stroke 20% · Depression 19% · Atrial fibrillation 17% · Cancer 16% · Heart failure 14% · COPD 11%.
The office billed $551,434, Medicare allowed $191,746 and paid $145,197; for 1,634 services of 20 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 538 | 1,634 | 76 | 1.22 | $551,434 | $145,197 |
| 2023 | 300 | 599 | 77 | 1.16 | $258,771 | $62,601 |
| 2022 | 275 | 476 | 77 | 1.25 | $201,543 | $49,671 |
| 2021 | 309 | 567 | 77 | 1.30 | $247,131 | $66,873 |
| 2020 | 275 | 539 | 77 | 1.52 | $215,572 | $53,708 |
| 2019 | 230 | 441 | 76 | 1.56 | $189,066 | $46,417 |
| 2018 | 228 | 440 | 76 | 1.51 | $192,846 | $45,139 |
| 2017 | 241 | 470 | 76 | 1.50 | $165,585 | $45,544 |
| 2016 | 231 | 457 | 76 | 1.43 | $147,827 | $41,542 |
| 2015 | 264 | 455 | 75 | 1.51 | $146,141 | $46,874 |
| 2014 | 272 | 475 | 75 | 1.41 | $133,286 | $42,215 |
| 2013 | 309 | 656 | 74 | 1.60 | $142,771 | $65,095 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Short return visit (20+ min) | 176 | $18,714 | $79 |
| New patient visit (45+ min) | 118 | $17,428 | $148 |
| Return visit (30+ min) | 107 | $13,679 | $111 |
| Nerve test | 14 | $3,033 | $217 |
| Long return visit (40+ min) | 15 | $2,552 | $170 |
| Muscle electrical test | 27 | $2,091 | $65 |
| New patient visit (30+ min) | 17 | $1,431 | $84 |
2022: 4 services
| Return visit (30+ min) | 110 | $15,096 | $110 |
| New patient visit (45+ min) | 83 | $12,846 | $155 |
| Short return visit (20+ min) | 123 | $12,822 | $80 |
| New patient visit (30+ min) | 25 | $2,272 | $91 |
2021: 9 services
| Return visit (30+ min) | 112 | $16,718 | $114 |
| New patient visit (45+ min) | 89 | $14,281 | $160 |
| Short return visit (20+ min) | 123 | $13,651 | $82 |
| New patient visit (60+ min) | 39 | $8,040 | $206 |
| Nerve test | 11 | $2,971 | $270 |
| Muscle electrical test | 29 | $2,240 | $70 |
| New patient visit (30+ min) | 17 | $1,763 | $104 |
| Nerve test | 11 | $1,647 | $150 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $1,407 | $70 |
2020: 10 services
| Return visit (30+ min) | 144 | $18,130 | $93 |
| New patient visit (60+ min) | 59 | $10,333 | $175 |
| New patient visit (45+ min) | 38 | $5,800 | $153 |
| Short return visit (20+ min) | 63 | $4,232 | $60 |
| Nerve test | 14 | $3,231 | $231 |
| Muscle electrical test | 31 | $2,138 | $59 |
| Nerve test | 13 | $1,982 | $142 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,899 | $70 |
| Long return visit (40+ min) | 14 | $1,637 | $117 |
| New patient visit (30+ min) | 17 | $1,575 | $93 |
2019: 8 services
| Return visit (30+ min) | 152 | $22,109 | $93 |
| New patient visit (60+ min) | 54 | $9,461 | $175 |
| Long return visit (40+ min) | 18 | $2,492 | $138 |
| New patient visit (45+ min) | 16 | $2,473 | $155 |
| Short return visit (20+ min) | 24 | $1,646 | $66 |
| Muscle electrical test | 20 | $1,455 | $61 |
| Nerve test | 11 | $1,198 | $109 |
| New patient visit (30+ min) | 12 | $1,197 | $100 |
2018: 5 services
| Return visit (30+ min) | 169 | $22,970 | $87 |
| New patient visit (60+ min) | 66 | $11,598 | $176 |
| Long return visit (40+ min) | 22 | $2,866 | $125 |
| Muscle electrical test | 17 | $1,195 | $60 |
| New patient visit (45+ min) | 11 | $1,188 | $108 |
2017: 6 services
| Return visit (30+ min) | 150 | $20,250 | $82 |
| New patient visit (60+ min) | 70 | $12,244 | $175 |
| New patient visit (45+ min) | 30 | $4,153 | $138 |
| Long return visit (40+ min) | 15 | $1,712 | $114 |
| Muscle electrical test | 19 | $1,015 | $53 |
| Short return visit (20+ min) | 12 | $716 | $60 |
2016: 6 services
| Return visit (30+ min) | 103 | $12,446 | $94 |
| Short return visit (20+ min) | 118 | $8,457 | $52 |
| New patient visit (60+ min) | 47 | $7,911 | $168 |
| New patient visit (45+ min) | 21 | $3,050 | $145 |
| Long return visit (40+ min) | 12 | $1,490 | $124 |
| Muscle electrical test | 12 | $745 | $57 |
2015: 6 services
| Short return visit (20+ min) | 164 | $17,032 | $66 |
| New patient visit (45+ min) | 58 | $9,134 | $157 |
| New patient visit (60+ min) | 23 | $4,294 | $187 |
| Nerve test | 14 | $3,706 | $265 |
| New patient visit (30+ min) | 36 | $3,618 | $100 |
| Return visit (30+ min) | 30 | $3,133 | $101 |
2014: 6 services
| Short return visit (20+ min) | 176 | $17,524 | $60 |
| New patient visit (60+ min) | 29 | $5,087 | $175 |
| Return visit (30+ min) | 47 | $4,557 | $95 |
| New patient visit (45+ min) | 29 | $4,287 | $148 |
| Nerve test | 14 | $3,460 | $247 |
| New patient visit (30+ min) | 33 | $3,162 | $96 |
2013: 9 services
| Short return visit (20+ min) | 144 | $16,552 | $64 |
| New patient visit (60+ min) | 89 | $16,310 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,778 | $176 |
| Return visit (30+ min) | 61 | $5,679 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $4,679 | $90 |
| New patient visit (45+ min) | 25 | $3,534 | $141 |
| Muscle electrical test | 14 | $1,620 | $116 |
| Measurement of brain wave activity (eeg), awake and drowsy | 14 | $664 | $47 |
| Measurement of brain wave activity (eeg), awake and asleep | 13 | $663 | $51 |
Drugs they prescribed that Part D paid
$366,592
Pharmacies billed $366,592 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (36 of 1,728) in 2024. Above the middle of the specialty; the typical neurology clinician is at 0%.
1,647 generic and 81 brand-name prescriptions · $366,592 in drug cost · 29 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Avonex Pen (4 Pack) | None | 13 | $124,714 | $9,593 |
| Copaxone | None | 13 | $77,009 | $5,924 |
| Emgality | Migraine | 11 | $7,612 | $692 |
| Rivastigmine | None | 25 | $7,467 | $299 |
| Lacosamide | None | 21 | $6,937 | $330 |
See all 38 drugs
| Avonex Pen (4 Pack) | None | 13 | $124,714 | $9,593 |
| Copaxone | None | 13 | $77,009 | $5,924 |
| Emgality | Migraine | 11 | $7,612 | $692 |
| Rivastigmine | None | 25 | $7,467 | $299 |
| Lacosamide | None | 21 | $6,937 | $330 |
| Memantine | None | 156 | $4,866 | $31 |
| Levetiracetam | None | 107 | $4,178 | $39 |
| Gabapentin | None | 182 | $4,006 | $22 |
| Donepezil | None | 261 | $3,758 | $14 |
| Sumatriptan | None | 24 | $2,094 | $87 |
| Carbidopa-Levodopa | None | 80 | $2,032 | $25 |
| Divalproex | None | 18 | $1,877 | $104 |
| Carbidopa-Levodopa Er | None | 32 | $1,840 | $57 |
| Phenytoin Sodium Extended | None | 27 | $1,533 | $57 |
| Amantadine | None | 29 | $1,526 | $53 |
| Pramipexole Dihydrochloride | None | 37 | $1,000 | $27 |
| Pregabalin | None | 29 | $903 | $31 |
| Baclofen | None | 36 | $808 | $22 |
| Carbamazepine | None | 19 | $766 | $40 |
| Primidone | None | 29 | $614 | $21 |
| Ondansetron | None | 11 | $605 | $55 |
| Propranolol | None | 33 | $565 | $17 |
| Risperidone | None | 20 | $553 | $28 |
| Amitriptyline | None | 42 | $469 | $11 |
| Duloxetine | None | 17 | $403 | $24 |
| Mirtazapine | None | 20 | $372 | $19 |
| Escitalopram | None | 23 | $348 | $15 |
| Rizatriptan | None | 20 | $248 | $12 |
| Clopidogrel | None | 28 | $230 | $8 |
| Ropinirole | None | 31 | $174 | $6 |
| Trazodone | None | 46 | $162 | $4 |
| Topiramate | None | 11 | $133 | $12 |
| Sertraline | None | 14 | $127 | $9 |
| Hydrocodone-Acetaminophen | None | 24 | $121 | $5 |
| Venlafaxine | None | 11 | $53 | $5 |
| Zolpidem | None | 11 | $41 | $4 |
| Meclizine | None | 13 | $40 | $3 |
| Tramadol | None | 12 | $11 | $1 |
Year by year
| 2024 | 1,728 | 394 | 2% (36) | 5% | $366,592 |
| 2023 | 1,775 | 335 | 2% (31) | 5% | $348,143 |
| 2022 | 1,451 | 304 | 2% (22) | None | $161,437 |
| 2021 | 1,757 | 337 | 1% (24) | 6% | $345,395 |
| 2020 | 1,668 | 292 | 1% (23) | None | $214,899 |
| 2019 | 1,810 | 312 | 1% (23) | None | $287,320 |
| 2018 | 1,931 | 314 | 2% (35) | None | $255,710 |
| 2017 | 2,140 | 327 | 1% (29) | None | $249,559 |
| 2016 | 2,419 | 330 | 1% (32) | None | $326,248 |
| 2015 | 2,635 | 341 | 1% (37) | None | $366,729 |
| 2014 | 2,464 | 345 | 2% (43) | None | $281,212 |
| 2013 | 2,129 | 302 | 3% (54) | None | $237,001 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 43 drugs
| Avonex | None | 13 | $112,285 | $8,637 |
| Nurtec Odt | None | 18 | $26,762 | $1,487 |
| Ubrelvy | None | 11 | $11,890 | $1,081 |
| Emgality | Migraine | 11 | $8,446 | $768 |
| Namzaric | None | 11 | $6,684 | $608 |
| Carbidopa-Levodopa | None | 87 | $6,081 | $70 |
| Memantine | None | 115 | $5,901 | $51 |
| Levetiracetam | None | 103 | $5,860 | $57 |
| Donepezil | None | 254 | $5,726 | $23 |
| Rivastigmine | None | 17 | $5,471 | $322 |
| Carbidopa-Levodopa Er | None | 45 | $4,892 | $109 |
| Gabapentin | None | 169 | $4,831 | $29 |
| Sumatriptan | None | 36 | $4,719 | $131 |
| Amantadine | None | 26 | $3,073 | $118 |
| Divalproex Sodium Er | None | 15 | $2,998 | $200 |
| Baclofen | None | 45 | $2,121 | $47 |
| Phenytoin Sodium Extended | None | 28 | $1,897 | $68 |
| Pramipexole Dihydrochloride | None | 39 | $1,596 | $41 |
| Divalproex | None | 12 | $1,537 | $128 |
| Lacosamide | None | 15 | $1,318 | $88 |
| Mirtazapine | None | 12 | $1,165 | $97 |
| Rizatriptan | None | 17 | $1,163 | $68 |
| Ropinirole | None | 22 | $1,116 | $51 |
| Pregabalin | None | 44 | $973 | $22 |
| Clopidogrel | None | 43 | $837 | $19 |
| Risperidone | None | 32 | $826 | $26 |
| Amitriptyline | None | 50 | $810 | $16 |
| Duloxetine | None | 20 | $786 | $39 |
| Primidone | None | 38 | $750 | $20 |
| Topiramate | None | 15 | $734 | $49 |
| Carbamazepine | None | 12 | $713 | $59 |
| Propranolol | None | 17 | $693 | $41 |
| Trazodone | None | 41 | $414 | $10 |
| Ondansetron | None | 14 | $399 | $28 |
| Butalbital-Acetaminophen-Caffe | None | 12 | $332 | $28 |
| Escitalopram | None | 29 | $237 | $8 |
| Meclizine | None | 18 | $181 | $10 |
| Hydrocodone-Acetaminophen | None | 15 | $154 | $10 |
| Quetiapine | None | 21 | $135 | $6 |
| Nortriptyline | None | 17 | $117 | $7 |
| Zolpidem | None | 13 | $82 | $6 |
| Tramadol | None | 15 | $39 | $3 |
| Venlafaxine | None | 12 | $13 | $1 |
2022: 33 drugs
| Rivastigmine | 35 | $15,469 | $442 |
| Sumatriptan | 40 | $6,951 | $174 |
| Levetiracetam | 76 | $5,053 | $66 |
| Memantine | 78 | $4,098 | $53 |
| Gabapentin | 147 | $3,573 | $24 |
| Carbidopa-Levodopa Er | 34 | $3,534 | $104 |
| Amantadine | 20 | $3,023 | $151 |
| Donepezil | 213 | $2,933 | $14 |
| Phenytoin Sodium Extended | 36 | $2,380 | $66 |
| Carbidopa-Levodopa | 54 | $2,363 | $44 |
| Pregabalin | 32 | $1,009 | $32 |
| Mirtazapine | 11 | $995 | $90 |
| Primidone | 49 | $978 | $20 |
| Pramipexole Dihydrochloride | 22 | $962 | $44 |
| Baclofen | 27 | $910 | $34 |
| Divalproex Sodium Er | 12 | $811 | $68 |
| Risperidone | 24 | $720 | $30 |
| Propranolol | 29 | $683 | $24 |
| Amitriptyline | 44 | $532 | $12 |
| Clopidogrel | 48 | $516 | $11 |
| Escitalopram | 38 | $503 | $13 |
| Trazodone | 37 | $369 | $10 |
| Ondansetron | 15 | $361 | $24 |
| Topiramate | 13 | $340 | $26 |
| Ropinirole | 11 | $339 | $31 |
| Rizatriptan | 11 | $324 | $29 |
| Lamotrigine | 12 | $323 | $27 |
| Atorvastatin | 13 | $183 | $14 |
| Venlafaxine | 11 | $172 | $16 |
| Hydrocodone-Acetaminophen | 13 | $157 | $12 |
| Pantoprazole | 11 | $132 | $12 |
| Citalopram Hbr | 13 | $120 | $9 |
| Nortriptyline | 11 | $118 | $11 |
2021: 38 drugs
| Rebif | 11 | $102,552 | $9,323 |
| Nurtec Odt | 14 | $27,356 | $1,954 |
| Rivastigmine | 49 | $20,721 | $423 |
| Vimpat | 12 | $10,905 | $909 |
| Neupro | 13 | $9,087 | $699 |
| Levetiracetam | 115 | $8,910 | $77 |
| Sumatriptan | 42 | $7,290 | $174 |
| Gabapentin | 199 | $5,479 | $28 |
| Entacapone | 13 | $4,770 | $367 |
| Carbidopa-Levodopa | 56 | $4,438 | $79 |
| Memantine | 91 | $4,117 | $45 |
| Carbidopa-Levodopa Er | 31 | $3,930 | $127 |
| Donepezil | 264 | $3,216 | $12 |
| Phenytoin Sodium Extended | 23 | $1,941 | $84 |
| Primidone | 46 | $1,332 | $29 |
| Propranolol | 34 | $1,250 | $37 |
| Ondansetron | 14 | $1,157 | $83 |
| Pregabalin | 26 | $1,043 | $40 |
| Baclofen | 47 | $865 | $18 |
| Mirtazapine | 22 | $812 | $37 |
| Duloxetine | 19 | $746 | $39 |
| Butalbital-Acetaminophen-Caffe | 14 | $718 | $51 |
| Risperidone | 28 | $668 | $24 |
| Amitriptyline | 63 | $651 | $10 |
| Clopidogrel | 56 | $643 | $11 |
| Escitalopram | 33 | $611 | $19 |
| Pramipexole Dihydrochloride | 20 | $454 | $23 |
| Topiramate | 13 | $422 | $32 |
| Ropinirole | 13 | $421 | $32 |
| Rizatriptan | 14 | $358 | $26 |
| Lamotrigine | 11 | $334 | $30 |
| Trazodone | 31 | $323 | $10 |
| Quetiapine | 18 | $199 | $11 |
| Sertraline | 13 | $110 | $8 |
| Simvastatin | 20 | $107 | $5 |
| Hydrocodone-Acetaminophen | 13 | $83 | $6 |
| Naproxen | 12 | $75 | $6 |
| Tramadol | 11 | $26 | $2 |
2020: 32 drugs
| Rivastigmine | 37 | $12,240 | $331 |
| Memantine Hcl Er | 13 | $6,278 | $483 |
| Levetiracetam | 112 | $5,658 | $51 |
| Sumatriptan | 37 | $5,361 | $145 |
| Carbidopa-Levodopa Er | 39 | $3,619 | $93 |
| Memantine | 90 | $3,260 | $36 |
| Phenytoin Sodium Extended | 46 | $3,179 | $69 |
| Gabapentin | 143 | $3,100 | $22 |
| Carbidopa-Levodopa | 45 | $2,698 | $60 |
| Donepezil | 260 | $2,663 | $10 |
| Tegretol | 12 | $2,416 | $201 |
| Amantadine | 16 | $2,355 | $147 |
| Pregabalin | 37 | $2,236 | $60 |
| Baclofen | 57 | $1,237 | $22 |
| Primidone | 51 | $1,111 | $22 |
| Mirtazapine | 32 | $1,015 | $32 |
| Clopidogrel | 70 | $890 | $13 |
| Duloxetine | 17 | $819 | $48 |
| Divalproex | 15 | $762 | $51 |
| Propranolol | 17 | $639 | $38 |
| Divalproex Sodium Er | 13 | $603 | $46 |
| Lamotrigine | 22 | $490 | $22 |
| Trazodone | 61 | $459 | $8 |
| Pramipexole Dihydrochloride | 18 | $431 | $24 |
| Quetiapine | 33 | $421 | $13 |
| Ropinirole | 11 | $355 | $32 |
| Amitriptyline | 40 | $317 | $8 |
| Topiramate | 13 | $266 | $20 |
| Escitalopram | 21 | $124 | $6 |
| Olanzapine | 11 | $90 | $8 |
| Tramadol | 16 | $21 | $1 |
| Meloxicam | 12 | $10 | $1 |
2019: 34 drugs
| Lyrica | 21 | $24,203 | $1,153 |
| Gabapentin | 157 | $9,468 | $60 |
| Rivastigmine | 32 | $8,671 | $271 |
| Memantine | 90 | $6,578 | $73 |
| Memantine Hcl Er | 20 | $6,539 | $327 |
| Levetiracetam | 134 | $4,914 | $37 |
| Sumatriptan | 28 | $4,331 | $155 |
| Donepezil | 267 | $3,774 | $14 |
| Carbidopa-Levodopa Er | 29 | $3,570 | $123 |
| Amantadine | 27 | $3,298 | $122 |
| Carbidopa-Levodopa | 40 | $3,290 | $82 |
| Phenytoin Sodium Extended | 51 | $2,310 | $45 |
| Selegiline | 11 | $1,763 | $160 |
| Mirtazapine | 44 | $1,761 | $40 |
| Primidone | 67 | $1,671 | $25 |
| Divalproex | 29 | $1,596 | $55 |
| Duloxetine | 20 | $1,413 | $71 |
| Propranolol | 28 | $1,229 | $44 |
| Propranolol Hcl Er | 14 | $1,223 | $87 |
| Pramipexole Dihydrochloride | 26 | $1,208 | $46 |
| Baclofen | 73 | $1,148 | $16 |
| Lamotrigine | 18 | $857 | $48 |
| Butalbital-Acetaminophen-Caffe | 24 | $638 | $27 |
| Clopidogrel | 45 | $623 | $14 |
| Ropinirole | 21 | $567 | $27 |
| Escitalopram | 37 | $510 | $14 |
| Quetiapine | 19 | $478 | $25 |
| Amitriptyline | 48 | $476 | $10 |
| Trazodone | 46 | $403 | $9 |
| Risperidone | 28 | $325 | $12 |
| Topiramate | 12 | $282 | $23 |
| Benztropine Mesylate | 11 | $119 | $11 |
| Simvastatin | 11 | $69 | $6 |
| Prednisone | 12 | $38 | $3 |
2018: 37 drugs
| Lyrica | 43 | $41,121 | $956 |
| Gabapentin | 150 | $11,051 | $74 |
| Memantine | 126 | $9,828 | $78 |
| Rivastigmine | 21 | $8,977 | $427 |
| Memantine Hcl Er | 15 | $8,010 | $534 |
| Entacapone | 11 | $7,330 | $666 |
| Donepezil | 346 | $6,038 | $17 |
| Levetiracetam | 143 | $4,621 | $32 |
| Sumatriptan | 32 | $4,558 | $142 |
| Carbidopa-Levodopa | 60 | $4,174 | $70 |
| Carbidopa-Levodopa Er | 27 | $3,292 | $122 |
| Duloxetine | 26 | $2,614 | $101 |
| Phenytoin Sodium Extended | 54 | $2,537 | $47 |
| Amantadine | 13 | $1,848 | $142 |
| Dilantin | 18 | $1,665 | $93 |
| Pramipexole Dihydrochloride | 32 | $1,466 | $46 |
| Propranolol Hcl Er | 22 | $1,361 | $62 |
| Lamotrigine | 25 | $1,284 | $51 |
| Ropinirole | 28 | $1,130 | $40 |
| Primidone | 40 | $1,124 | $28 |
| Propranolol | 29 | $962 | $33 |
| Quetiapine | 31 | $804 | $26 |
| Butalb-Caff-Acetaminoph-Codein | 13 | $787 | $61 |
| Baclofen | 55 | $779 | $14 |
| Ondansetron | 14 | $661 | $47 |
| Escitalopram | 44 | $608 | $14 |
| Mirtazapine | 11 | $554 | $50 |
| Clopidogrel | 58 | $533 | $9 |
| Risperidone | 48 | $474 | $10 |
| Butalbital-Acetaminophen-Caffe | 17 | $473 | $28 |
| Divalproex | 29 | $464 | $16 |
| Amitriptyline | 42 | $355 | $8 |
| Trazodone | 47 | $326 | $7 |
| Naproxen | 11 | $143 | $13 |
| Nortriptyline | 12 | $93 | $8 |
| Prednisone | 12 | $69 | $6 |
| Tramadol | 11 | $65 | $6 |
2017: 42 drugs
| Lyrica | 43 | $37,102 | $863 |
| Namenda Xr | 40 | $21,193 | $530 |
| Rivastigmine | 36 | $12,956 | $360 |
| Vimpat | 11 | $8,127 | $739 |
| Entacapone | 22 | $6,392 | $291 |
| Donepezil | 380 | $5,368 | $14 |
| Gabapentin | 187 | $4,706 | $25 |
| Memantine | 76 | $4,337 | $57 |
| Sumatriptan | 24 | $3,829 | $160 |
| Amantadine | 25 | $3,806 | $152 |
| Carbidopa-Levodopa Er | 35 | $3,528 | $101 |
| Levetiracetam | 129 | $3,161 | $25 |
| Carbidopa-Levodopa | 100 | $3,037 | $30 |
| Dilantin | 19 | $2,509 | $132 |
| Phenytoin Sodium Extended | 49 | $2,196 | $45 |
| Carbamazepine Er | 14 | $2,178 | $156 |
| Divalproex Sodium Er | 12 | $1,416 | $118 |
| Duloxetine | 27 | $1,192 | $44 |
| Carbamazepine | 11 | $968 | $88 |
| Mirtazapine | 18 | $948 | $53 |
| Verapamil Er | 26 | $947 | $36 |
| Clopidogrel | 86 | $881 | $10 |
| Lamotrigine | 27 | $874 | $32 |
| Primidone | 45 | $852 | $19 |
| Butalb-Caff-Acetaminoph-Codein | 12 | $822 | $69 |
| Pramipexole Dihydrochloride | 17 | $800 | $47 |
| Baclofen | 51 | $777 | $15 |
| Ropinirole | 21 | $737 | $35 |
| Divalproex | 31 | $632 | $20 |
| Topiramate | 29 | $502 | $17 |
| Amitriptyline | 56 | $480 | $9 |
| Risperidone | 57 | $435 | $8 |
| Propranolol | 25 | $398 | $16 |
| Butalbital-Acetaminophen-Caffe | 14 | $355 | $25 |
| Escitalopram | 42 | $326 | $8 |
| Trazodone | 48 | $213 | $4 |
| Paroxetine | 11 | $198 | $18 |
| Quetiapine | 13 | $149 | $11 |
| Citalopram Hbr | 11 | $81 | $7 |
| Nortriptyline | 14 | $73 | $5 |
| Prednisone | 12 | $67 | $6 |
| Hydrocodone-Acetaminophen | 12 | $58 | $5 |
2016: 49 drugs
| Namenda Xr | 57 | $25,174 | $442 |
| Rivastigmine | 45 | $19,164 | $426 |
| Azilect | 20 | $18,666 | $933 |
| Lyrica | 28 | $14,187 | $507 |
| Gabapentin | 204 | $9,460 | $46 |
| Vimpat | 12 | $8,424 | $702 |
| Entacapone | 16 | $5,776 | $361 |
| Donepezil | 408 | $5,569 | $14 |
| Carbidopa-Levodopa Er | 34 | $4,629 | $136 |
| Memantine | 75 | $3,374 | $45 |
| Amantadine | 16 | $3,205 | $200 |
| Galantamine Hbr | 19 | $3,172 | $167 |
| Dilantin | 28 | $2,880 | $103 |
| Divalproex Sodium Er | 28 | $2,837 | $101 |
| Levetiracetam | 127 | $2,791 | $22 |
| Carbidopa-Levodopa | 95 | $2,682 | $28 |
| Modafinil | 11 | $2,323 | $211 |
| Duloxetine | 55 | $2,114 | $38 |
| Sumatriptan | 15 | $1,872 | $125 |
| Ropinirole | 24 | $1,666 | $69 |
| Propranolol | 42 | $1,435 | $34 |
| Phenytoin Sodium Extended | 26 | $1,229 | $47 |
| Lamotrigine | 37 | $1,167 | $32 |
| Primidone | 49 | $1,129 | $23 |
| Mirtazapine | 32 | $1,119 | $35 |
| Baclofen | 41 | $1,024 | $25 |
| Valproic Acid | 15 | $977 | $65 |
| Carbamazepine | 11 | $949 | $86 |
| Pramipexole Dihydrochloride | 23 | $936 | $41 |
| Clopidogrel | 70 | $844 | $12 |
| Oxcarbazepine | 21 | $759 | $36 |
| Divalproex | 30 | $695 | $23 |
| Risperidone | 72 | $650 | $9 |
| Topiramate | 50 | $643 | $13 |
| Butalbital-Acetaminophen-Caffe | 25 | $626 | $25 |
| Verapamil Er | 24 | $610 | $25 |
| Rizatriptan | 13 | $473 | $36 |
| Fluoxetine | 13 | $412 | $32 |
| Hydrocodone-Acetaminophen | 14 | $378 | $27 |
| Ondansetron | 25 | $368 | $15 |
| Amitriptyline | 29 | $367 | $13 |
| Paroxetine | 24 | $331 | $14 |
| Quetiapine | 34 | $329 | $10 |
| Escitalopram | 37 | $281 | $8 |
| Trazodone | 53 | $251 | $5 |
| Clonazepam | 22 | $245 | $11 |
| Zolpidem | 17 | $227 | $13 |
| Sertraline | 18 | $129 | $7 |
| Lorazepam | 14 | $52 | $4 |
2015: 51 drugs
| Gilenya | 12 | $66,882 | $5,573 |
| Namenda Xr | 93 | $36,299 | $390 |
| Exelon | 33 | $19,382 | $587 |
| Azilect | 25 | $18,371 | $735 |
| Namenda | 47 | $17,155 | $365 |
| Gabapentin | 232 | $9,417 | $41 |
| Lyrica | 25 | $9,107 | $364 |
| Entacapone | 23 | $6,756 | $294 |
| Carbidopa-Levodopa | 133 | $5,310 | $40 |
| Donepezil | 392 | $5,200 | $13 |
| Divalproex Sodium Er | 21 | $4,547 | $217 |
| Levetiracetam | 132 | $3,842 | $29 |
| Carbidopa-Levodopa Er | 32 | $3,719 | $116 |
| Modafinil | 11 | $3,609 | $328 |
| Amantadine | 24 | $3,277 | $137 |
| Galantamine Hbr | 22 | $2,591 | $118 |
| Sumatriptan | 31 | $2,219 | $72 |
| Ropinirole | 42 | $1,887 | $45 |
| Pyridostigmine | 27 | $1,702 | $63 |
| Lamotrigine | 58 | $1,689 | $29 |
| Pramipexole Dihydrochloride | 36 | $1,592 | $44 |
| Dilantin | 25 | $1,577 | $63 |
| Valproic Acid | 29 | $1,535 | $53 |
| Memantine | 24 | $1,380 | $57 |
| Duloxetine | 29 | $1,292 | $45 |
| Butalbital-Acetaminophen-Caffe | 46 | $1,292 | $28 |
| Carbamazepine | 20 | $1,157 | $58 |
| Propranolol Hcl Er | 14 | $1,053 | $75 |
| Baclofen | 42 | $1,046 | $25 |
| Propranolol | 43 | $988 | $23 |
| Clopidogrel | 76 | $938 | $12 |
| Primidone | 37 | $900 | $24 |
| Risperidone | 70 | $781 | $11 |
| Amitriptyline | 48 | $704 | $15 |
| Phenytoin Sodium Extended | 11 | $704 | $64 |
| Topiramate | 49 | $641 | $13 |
| Quetiapine | 40 | $591 | $15 |
| Paroxetine | 60 | $483 | $8 |
| Verapamil Er | 24 | $456 | $19 |
| Divalproex | 27 | $413 | $15 |
| Trazodone | 63 | $303 | $5 |
| Fluoxetine | 14 | $256 | $18 |
| Sertraline | 27 | $243 | $9 |
| Hydrocodone-Acetaminophen | 13 | $194 | $15 |
| Clonazepam | 35 | $187 | $5 |
| Naproxen | 15 | $163 | $11 |
| Escitalopram | 19 | $161 | $8 |
| Zolpidem | 16 | $121 | $8 |
| Citalopram Hbr | 23 | $76 | $3 |
| Tramadol | 14 | $49 | $3 |
| Simvastatin | 13 | $39 | $3 |
2014: 49 drugs
| Copaxone | 11 | $58,633 | $5,330 |
| Namenda | 109 | $36,523 | $335 |
| Exelon | 39 | $17,741 | $455 |
| Azilect | 18 | $11,541 | $641 |
| Lyrica | 22 | $8,039 | $365 |
| Carbidopa-Levodopa | 140 | $6,042 | $43 |
| Levetiracetam | 109 | $5,311 | $49 |
| Gabapentin | 221 | $5,011 | $23 |
| Namenda Xr | 17 | $4,667 | $275 |
| Donepezil | 360 | $4,498 | $12 |
| Galantamine Hbr | 32 | $4,283 | $134 |
| Aggrenox | 12 | $4,009 | $334 |
| Pramipexole Dihydrochloride | 32 | $2,877 | $90 |
| Divalproex Sodium Er | 20 | $2,752 | $138 |
| Ropinirole | 66 | $2,563 | $39 |
| Sumatriptan | 46 | $2,364 | $51 |
| Quetiapine | 51 | $2,157 | $42 |
| Dilantin | 33 | $2,127 | $64 |
| Selegiline | 14 | $1,977 | $141 |
| Valproic Acid | 34 | $1,810 | $53 |
| Amantadine | 15 | $1,564 | $104 |
| Carbidopa-Levodopa Er | 32 | $1,511 | $47 |
| Lamotrigine | 54 | $1,292 | $24 |
| Carbamazepine | 18 | $1,223 | $68 |
| Risperidone | 74 | $957 | $13 |
| Phenytoin Sodium Extended | 24 | $849 | $35 |
| Butalbital-Acetaminophen-Caffe | 45 | $825 | $18 |
| Baclofen | 48 | $802 | $17 |
| Amitriptyline | 86 | $658 | $8 |
| Escitalopram | 49 | $632 | $13 |
| Clopidogrel | 45 | $608 | $14 |
| Topiramate | 42 | $509 | $12 |
| Pyridostigmine | 17 | $474 | $28 |
| Paroxetine | 43 | $364 | $8 |
| Divalproex | 38 | $335 | $9 |
| Trazodone | 45 | $224 | $5 |
| Propranolol | 34 | $220 | $6 |
| Butalb-Caff-Acetaminoph-Codein | 15 | $218 | $15 |
| Primidone | 13 | $207 | $16 |
| Simvastatin | 23 | $206 | $9 |
| Omeprazole | 11 | $196 | $18 |
| Verapamil Er | 11 | $195 | $18 |
| Clonazepam | 16 | $186 | $12 |
| Trihexyphenidyl | 17 | $173 | $10 |
| Zolpidem | 20 | $128 | $6 |
| Citalopram Hbr | 22 | $119 | $5 |
| Sertraline | 15 | $113 | $8 |
| Tramadol | 18 | $102 | $6 |
| Fluoxetine | 12 | $47 | $4 |
2013: 44 drugs
| Copaxone | 11 | $53,508 | $4,864 |
| Namenda | 78 | $26,192 | $336 |
| Exelon | 41 | $16,578 | $404 |
| Lyrica | 28 | $10,096 | $361 |
| Vimpat | 12 | $7,652 | $638 |
| Levetiracetam | 112 | $7,050 | $63 |
| Carbidopa-Levodopa | 159 | $5,867 | $37 |
| Entacapone | 15 | $5,700 | $380 |
| Donepezil | 306 | $5,434 | $18 |
| Aggrenox | 17 | $4,675 | $275 |
| Gabapentin | 174 | $4,403 | $25 |
| Galantamine Hbr | 29 | $4,210 | $145 |
| Quetiapine | 21 | $4,033 | $192 |
| Ropinirole | 53 | $2,703 | $51 |
| Pramipexole Dihydrochloride | 21 | $2,561 | $122 |
| Carbidopa-Levodopa Er | 48 | $2,318 | $48 |
| Dilantin | 25 | $2,290 | $92 |
| Selegiline | 13 | $1,954 | $150 |
| Primidone | 30 | $1,433 | $48 |
| Clopidogrel | 67 | $1,325 | $20 |
| Divalproex Sodium Er | 13 | $1,303 | $100 |
| Venlafaxine Hcl Er | 11 | $817 | $74 |
| Butalb-Caff-Acetaminoph-Codein | 26 | $741 | $29 |
| Paroxetine | 67 | $720 | $11 |
| Lamotrigine | 39 | $713 | $18 |
| Phenytoin Sodium Extended | 24 | $688 | $29 |
| Valproic Acid | 20 | $605 | $30 |
| Carbamazepine | 20 | $575 | $29 |
| Sumatriptan | 22 | $572 | $26 |
| Pyridostigmine | 18 | $564 | $31 |
| Risperidone | 25 | $523 | $21 |
| Propranolol | 60 | $455 | $8 |
| Topiramate | 30 | $380 | $13 |
| Amitriptyline | 71 | $304 | $4 |
| Trazodone | 40 | $241 | $6 |
| Trihexyphenidyl | 20 | $195 | $10 |
| Cyclobenzaprine | 21 | $174 | $8 |
| Sertraline | 21 | $156 | $7 |
| Simvastatin | 15 | $152 | $10 |
| Baclofen | 28 | $142 | $5 |
| Clonazepam | 13 | $110 | $8 |
| Lorazepam | 18 | $107 | $6 |
| Citalopram Hbr | 17 | $101 | $6 |
| Zolpidem | 12 | $81 | $7 |
Money from drug and device companies
$4,674 in 2025
| 2025 | 35 | 169 | None | $4,674 |
| 2024 | 19 | 50 | None | $1,275 |
| 2019 | 1 | 1 | None | $18 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alexion Pharmaceuticals | Ultomiris | $483 | 10 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $438 | 15 payments
|
| SK Life Science | None | $434 | 24 payments
|
| Noctrix Health | Nidra | $349 | 1 payment
|
| Pfizer | Nurtec Odt | $261 | 11 payments
|
| Abbvie | Qulipta | $252 | 14 payments
|
See all 169 published payments
| SK Life Science | Meals · 2025-12-23 | None | $32 |
| Abbvie | Meals · 2025-12-18 | Botox | $17 |
| Ipsen Biopharmaceuticals | Meals · 2025-12-16 | Dysport | $27 |
| Teva Pharmaceuticals USA | Meals · 2025-12-15 | Austedo Xr | $35 |
| Teva Pharmaceuticals USA | Meals · 2025-12-15 | Austedo Xr | $35 |
| Vanda Pharmaceuticals | Meals · 2025-12-12 | Ponvory | $32 |
| Jazz Pharmaceuticals | Meals · 2025-12-12 | Epidiolex | $19 |
| Argenx US | Meals · 2025-12-10 | Vyvgart Hytrulo | $33 |
| ACADIA Pharmaceuticals | Meals · 2025-12-10 | Nuplazid | $24 |
| Amgen | Meals · 2025-12-08 | None | $20 |
| Octapharma USA | Meals · 2025-12-04 | Panzyga | $27 |
| Lundbeck | Meals · 2025-12-03 | Vyepti | $23 |
| Pfizer | Meals · 2025-12-02 | Nurtec Odt | $21 |
| Janssen Biotech | Education · 2025-12-01 | None | $85 |
| SK Life Science | Meals · 2025-11-25 | None | $12 |
| Janssen Biotech | Meals · 2025-11-24 | None | $34 |
| Axsome Therapeutics | Meals · 2025-11-22 | Symbravo | $24 |
| Amneal Pharmaceuticals | Meals · 2025-11-20 | Crexont | $22 |
| Pfizer | Meals · 2025-11-18 | Nurtec Odt | $24 |
| Eisai | Meals · 2025-11-17 | Leqembi | $19 |
| Abbvie | Meals · 2025-11-12 | Ubrelvy | $4 |
| Teva Pharmaceuticals USA | Meals · 2025-11-12 | Austedo Xr | $3 |
| Teva Pharmaceuticals USA | Meals · 2025-11-12 | Austedo Xr | $32 |
| Alexion Pharmaceuticals | Meals · 2025-11-11 | Ultomiris | $31 |
| SK Life Science | Meals · 2025-11-08 | None | $35 |
| Vanda Pharmaceuticals | Meals · 2025-11-07 | Ponvory | $37 |
| CSL Behring | Meals · 2025-11-04 | Hizentra | $23 |
| Teva Pharmaceuticals USA | Meals · 2025-10-31 | Austedo Xr | $32 |
| Lundbeck | Meals · 2025-10-31 | Vyepti | $0 |
| Lundbeck | Meals · 2025-10-31 | Vyepti | $29 |
| Ucb | Meals · 2025-10-28 | Nayzilam | $21 |
| Pfizer | Meals · 2025-10-28 | Nurtec Odt | $26 |
| TG Therapeutics | Meals · 2025-10-25 | Briumvi | $28 |
| Merz Pharmaceuticals | Meals · 2025-10-23 | Xeomin | $28 |
| Neurocrine BioSciences | Meals · 2025-10-21 | Ingrezza | $33 |
| Otsuka America Pharmaceutical | Meals · 2025-10-20 | Rexulti | $20 |
| Axsome Therapeutics | Meals · 2025-10-17 | Symbravo | $28 |
| Eisai | Meals · 2025-10-16 | Leqembi | $32 |
| TG Therapeutics | Meals · 2025-10-08 | Briumvi | $34 |
| Grifols USA | Meals · 2025-10-03 | Gamunex-C | $31 |
| SK Life Science | Meals · 2025-10-03 | None | $34 |
| Teva Pharmaceuticals USA | Meals · 2025-09-30 | Austedo Xr | $25 |
| Pfizer | Meals · 2025-09-24 | Nurtec Odt | $29 |
| Alexion Pharmaceuticals | Meals · 2025-09-23 | Ultomiris | $32 |
| Lundbeck | Meals · 2025-09-23 | Vyepti | $24 |
| Janssen Biotech | Meals · 2025-09-18 | None | $33 |
| Abbvie | Meals · 2025-09-17 | Ubrelvy | $25 |
| ACADIA Pharmaceuticals | Meals · 2025-09-16 | Nuplazid | $21 |
| Teva Pharmaceuticals USA | Meals · 2025-09-09 | Austedo Xr | $36 |
| Argenx US | Meals · 2025-09-08 | Vyvgart Hytrulo | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-05 | Wainua | $16 |
| SK Life Science | Meals · 2025-09-04 | None | $1 |
| SK Life Science | Meals · 2025-09-04 | None | $8 |
| Abbvie | Meals · 2025-09-03 | Botox | $14 |
| Neurocrine BioSciences | Meals · 2025-09-03 | Ingrezza | $31 |
| Abbvie | Meals · 2025-08-29 | Ubrelvy | $28 |
| Merz Pharmaceuticals | Meals · 2025-08-27 | Xeomin | $19 |
| SK Life Science | Meals · 2025-08-23 | None | $34 |
| Lundbeck | Meals · 2025-08-21 | Vyepti | $20 |
| Lundbeck | Meals · 2025-08-21 | Vyepti | $0 |
| Jazz Pharmaceuticals | Meals · 2025-08-20 | Epidiolex | $27 |
| Alexion Pharmaceuticals | Meals · 2025-08-19 | Ultomiris | $33 |
| Pfizer | Meals · 2025-08-19 | Nurtec Odt | $17 |
| Mallinckrodt Hospital Products | Meals · 2025-08-08 | Acthar | $27 |
| Eisai | Meals · 2025-08-06 | Leqembi | $28 |
| Abbvie | Meals · 2025-08-05 | Qulipta | $26 |
| Neurelis | Meals · 2025-08-05 | Valtoco | $41 |
| Teva Pharmaceuticals USA | Meals · 2025-07-31 | Austedo Xr | $35 |
| Lilly USA | Meals · 2025-07-29 | Kisunla | $27 |
| SK Life Science | Meals · 2025-07-28 | None | $0 |
| SK Life Science | Meals · 2025-07-28 | None | $10 |
| Octapharma USA | Meals · 2025-07-22 | Panzyga | $24 |
| Neurocrine BioSciences | Meals · 2025-07-17 | Ingrezza | $29 |
| Neurocrine BioSciences | Meals · 2025-07-17 | Ingrezza | $8 |
| Pfizer | Meals · 2025-07-16 | Nurtec Odt | $21 |
| SK Life Science | Meals · 2025-07-14 | None | $34 |
| Mallinckrodt Hospital Products | Meals · 2025-07-11 | Acthar | $19 |
| CSL Behring | Meals · 2025-07-11 | Hizentra | $28 |
| SK Life Science | Meals · 2025-07-10 | None | $10 |
| Lundbeck | Meals · 2025-07-08 | Vyepti | $15 |
| Biogen | Meals · 2025-07-02 | Skyclarys | $23 |
| Abbvie | Meals · 2025-06-27 | Qulipta | $8 |
| Lundbeck | Meals · 2025-06-27 | Vyepti | $8 |
| Merz Pharmaceuticals | Meals · 2025-06-26 | Xeomin | $30 |
| Pfizer | Meals · 2025-06-23 | Nurtec Odt | $27 |
| Teva Pharmaceuticals USA | Meals · 2025-06-18 | Austedo Xr | $39 |
| Alexion Pharmaceuticals | Meals · 2025-06-17 | Ultomiris | $30 |
| BridgeBio Pharma | Meals · 2025-06-13 | Attruby | $32 |
| Neurocrine BioSciences | Meals · 2025-06-12 | Ingrezza | $34 |
| Otsuka America Pharmaceutical | Meals · 2025-06-11 | Rexulti | $26 |
| SK Life Science | Meals · 2025-06-11 | None | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-05 | Wainua | $18 |
| Eisai | Meals · 2025-06-02 | Leqembi | $20 |
| Alexion Pharmaceuticals | Meals · 2025-05-29 | Ultomiris | $135 |
| Alexion Pharmaceuticals | Meals · 2025-05-29 | Ultomiris | $135 |
| Lundbeck | Meals · 2025-05-29 | Vyepti | $28 |
| Pfizer | Meals · 2025-05-28 | Nurtec Odt | $23 |
| Janssen Biotech | Meals · 2025-05-27 | None | $40 |
| CSL Behring | Meals · 2025-05-16 | Hizentra | $26 |
| Lilly USA | Meals · 2025-05-15 | Kisunla | $26 |
| Abbvie | Meals · 2025-05-14 | Qulipta | $25 |
| Teva Pharmaceuticals USA | Meals · 2025-05-09 | Austedo Xr | $21 |
| Alexion Pharmaceuticals | Meals · 2025-05-06 | Ultomiris | $31 |
| SK Life Science | Meals · 2025-05-02 | None | $31 |
| Teva Pharmaceuticals USA | Meals · 2025-05-01 | Austedo Xr | $29 |
| Biogen | Meals · 2025-04-30 | Skyclarys | $29 |
| Eisai | Meals · 2025-04-30 | Leqembi | $22 |
| Lundbeck | Meals · 2025-04-28 | Vyepti | $18 |
| Merz Pharmaceuticals | Meals · 2025-04-25 | Xeomin | $37 |
| SK Life Science | Meals · 2025-04-25 | None | $1 |
| SK Life Science | Meals · 2025-04-25 | None | $7 |
| Pfizer | Meals · 2025-04-24 | Nurtec Odt | $25 |
| ACADIA Pharmaceuticals | Meals · 2025-04-22 | Nuplazid | $30 |
| Boston Scientific | Meals · 2025-04-21 | General - Dbs | $134 |
| Teva Pharmaceuticals USA | Meals · 2025-04-16 | Austedo Xr | $35 |
| Otsuka America Pharmaceutical | Meals · 2025-04-15 | Rexulti | $19 |
| Amneal Pharmaceuticals | Meals · 2025-04-11 | Rytary | $26 |
| Neurocrine BioSciences | Meals · 2025-04-10 | Ingrezza | $30 |
| Lundbeck | Meals · 2025-04-09 | Vyepti | $8 |
| SK Life Science | Meals · 2025-04-08 | None | $26 |
| Neurelis | Meals · 2025-04-07 | Valtoco | $24 |
| Abbvie | Meals · 2025-04-04 | Qulipta | $3 |
| Biogen | Meals · 2025-04-04 | Vumerity | $27 |
| Lilly USA | Meals · 2025-04-03 | Kisunla | $32 |
| SK Life Science | Meals · 2025-04-03 | None | $8 |
| Octapharma USA | Meals · 2025-04-01 | Panzyga | $35 |
| Pfizer | Meals · 2025-03-31 | Nurtec Odt | $19 |
| Ucb | Meals · 2025-03-28 | Briviact | $18 |
| Noctrix Health | Meals · 2025-03-27 | Nidra | $349 |
| Eisai | Meals · 2025-03-26 | Leqembi | $22 |
| Argenx US | Meals · 2025-03-25 | Vyvgart Hytrulo | $24 |
| Alexion Pharmaceuticals | Meals · 2025-03-24 | Ultomiris | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-03-19 | Austedo Xr | $26 |
| Lundbeck | Meals · 2025-03-19 | Vyepti | $32 |
| SK Life Science | Meals · 2025-03-18 | None | $9 |
| EMD Serono | Meals · 2025-03-17 | None | $21 |
| Abbvie | Meals · 2025-03-12 | Ubrelvy | $21 |
| Abbvie | Meals · 2025-03-06 | Qulipta | $8 |
| Amneal Pharmaceuticals | Meals · 2025-03-06 | Rytary | $23 |
| SK Life Science | Meals · 2025-03-06 | None | $9 |
| Abbvie | Meals · 2025-03-05 | Botox | $20 |
| Otsuka America Pharmaceutical | Meals · 2025-03-04 | Rexulti | $20 |
| Grifols USA | Meals · 2025-03-03 | Gamunex-C | $27 |
| Amgen | Meals · 2025-02-27 | Uplizna | $24 |
| Neurelis | Meals · 2025-02-26 | Valtoco | $17 |
| Lilly USA | Meals · 2025-02-25 | Kisunla | $22 |
| Alexion Pharmaceuticals | Meals · 2025-02-24 | Ultomiris | $25 |
| Alexion Pharmaceuticals | Meals · 2025-02-24 | Ultomiris | $2 |
| Ucb | Meals · 2025-02-21 | Rystiggo | $25 |
| SK Life Science | Meals · 2025-02-21 | None | $34 |
| Eisai | Meals · 2025-02-19 | Leqembi | $32 |
| Abbvie | Meals · 2025-02-18 | Botox | $28 |
| Pfizer | Meals · 2025-02-17 | Nurtec Odt | $28 |
| Impel Pharmaceuticals | Meals · 2025-02-11 | Trudhesa | $18 |
| Teva Pharmaceuticals USA | Meals · 2025-02-06 | Austedo Xr | $31 |
| ANI Pharmaceuticals | Meals · 2025-02-05 | Purified Cortrophin Gel | $29 |
| Neurocrine BioSciences | Meals · 2025-02-04 | Ingrezza | $34 |
| SK Life Science | Meals · 2025-01-28 | None | $19 |
| Abbvie | Meals · 2025-01-23 | Qulipta | $24 |
| SK Life Science | Meals · 2025-01-20 | None | $21 |
| SK Life Science | Meals · 2025-01-20 | None | $3 |
| Biogen | Meals · 2025-01-16 | Skyclarys | $30 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $12 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $1 |
| Lundbeck | Meals · 2025-01-16 | Vyepti | $2 |
| EMD Serono | Meals · 2025-01-14 | None | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-01-09 | Austedo Xr | $24 |
| Ucb | Meals · 2025-01-06 | Briviact | $20 |
| SK Life Science | Meals · 2025-01-03 | None | $23 |
See earlier years (2024, 2019)
2024: $1,275
| Teva Pharmaceuticals USA | Austedo Xr | $185 | 7 payments
|
| Abbvie | Botox | $163 | 6 payments
|
| SK Life Science | None | $153 | 8 payments
|
| Biogen | Skyclarys | $102 | 4 payments
|
| Alexion Pharmaceuticals | Ultomiris | $90 | 3 payments
|
| Eisai | Leqembi | $84 | 3 payments
|
| Argenx US | Vyvgart Hytrulo | $81 | 3 payments
|
| Neurocrine Biosciences | Ingrezza | $65 | 2 payments
|
| EMD Serono | None | $58 | 2 payments
|
| Pfizer | Nurtec Odt | $50 | 2 payments
|
| Genentech USA | Ocrevus | $50 | 2 payments
|
| Neurelis | Valtoco | $29 | 1 payment
|
| Octapharma USA | Panzyga | $28 | 1 payment
|
| Lundbeck | Vyepti | $27 | 1 payment
|
| Ucb | Briviact | $25 | 1 payment
|
| Lilly USA | Kisunla | $22 | 1 payment
|
| Life Molecular Imaging | Neuraceq | $22 | 1 payment
|
| Averitas Pharma | Qutenza | $21 | 1 payment
|
| Azurity Pharmaceuticals | None | $20 | 1 payment
|
2019: $18
| Davol | None | $18 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1497763536
- Licence
- CA A79159California A79159: Current · expires 2027-12-31
- Trained
- Virginia Commonwealth University, School of Medicine, 2000
- Group
- Bass Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A791590
- Taxonomy
- Neurology (2084N0400X)
- Mailing address
- 18431 Technology Dr, Morgan Hill, CA, 95037
- NPI first listed
- 2006-08-04
- NPI last updated
- 2025-02-28
- NPI record certified
- 2025-02-28
This is when the NPI record was last certified, not a medical board exam.